Increased Expression of Cyclooxygenase-2 (COX-2) in Radiation-Induced Small Bowel Injury in Rats

Journal of Surgical Research

Volumn 135, Issue 1, 2006, Pages 76-84

  Keskek, Mehmet ^a   Gocmen, Erdal ^a   Kilic, Mehmet ^a   Gencturk, Serra ^a   Can, Bilge ^b   Cengiz, Mustafa ^b   Okten, R Murat ^c   Koc, Mahmut ^a  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

^c Duzen Laboratories   (Turkey)

Author keywords

cyclooxygenase 2; fibrosis; inflammation; radiation; rofecoxib; small intestine

Indexed keywords

CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; MALONALDEHYDE; MYELOPEROXIDASE; ROFECOXIB;

ABDOMEN; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL TYPE; CONTROLLED STUDY; DIARRHEA; DRUG EFFECT; ENDOTHELIUM CELL; ENZYME ACTIVITY; FIBROBLAST; INTESTINE INJURY; INTESTINE WALL; IRRADIATION; LYMPHADENOPATHY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION INJURY; RANDOMIZATION; RAT; STATISTICAL SIGNIFICANCE; VASCULAR ENDOTHELIUM;

ACUTE DISEASE; ANIMALS; APOPTOSIS; CHRONIC DISEASE; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; DISEASE MODELS, ANIMAL; ENTERITIS; INTESTINE, SMALL; LACTONES; MALE; MALONDIALDEHYDE; PEROXIDASE; RADIATION INJURIES, EXPERIMENTAL; RATS; RATS, SPRAGUE-DAWLEY; SULFONES;

EID: 33747071444     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2006.03.031     Document Type: Article

References (43)

1. Dubois A., and Walker R.I. Prospects for management of gastrointestinal injury associated with the acute radiation syndrome. Gastroenterology 95 (1988) 500
2. Johnson R.J., and Carrington B.M. Pelvic radiation disease. Clin Radiol 45 (1992) 4
3. Hwang J.M., Chan D.C., Tsao T.Y., Tsou S.S., Lu R.H., and Tsai L.M. Effects of oral arginine and glutamine on radiation-induced injury in the rat. J Surg Res 109 (2003) 149
4. Touboul E., Balosso J., Schlienger M., and Laugier A. Radiation injury of the small intestine. Radiobiological, radiopathological aspects; risk factors and prevention. Ann Chir 50 (1996) 58
5. Needleman P., and Isaksen P.C. The discovery and function of COX-2. J Rheumatol 24 (1997) 6
6. Seibert K., Masferrer J., Zhang Y., et al. Mediation of inflammation by cyclooxygenase-2. Agents Actions Suppl 46 (1995) 41
7. Iseki S. Immunocytochemical localization of cyclooxygenase-1 and cyclooxygenase-2 in the rat stomach. Histochem J 27 (1995) 323
8. Simon L.S. Role and regulation of cyclooxygenase-2 during inflammation. Am J Med 106 (1999) 37
9. Yamamoto H., Kondo M., Nakamori S., et al. JTE-522, a cyclooxygenase-2 inhibitor, is an effective chemopreventive agent against rat experimental liver fibrosis 1. Gastroenterology 125 (2003) 556
10. Cheng J., Imanishi H., Iijima H., et al. Expression of cyclooxygenase 2 and cytosolic phospholipase A(2) in the liver tissue of patients with chronic hepatitis and liver cirrhosis. Hepatol Res 23 (2002) 185
11. Tsai C.H., Chou M.Y., and Chang Y.C. The up-regulation of cyclooxygenase-2 expression in human buccal mucosal fibroblasts by arecoline. A possible role in the pathogenesis of oral submucous fibrosis. J Oral Pathol Med 32 (2003) 146
12. McLean A.L., Talmor M., Harper A., et al. Expression of cyclooxygenase-2 in the periprosthetic capsule surrounding a silicone shell implant in the rat. Ann Plastic Surg 48 (2002) 292
13. Sonis S.T., O'Donnell K.E., Popat R., et al. The relationship between mucosal cyclooxygenase-2 (COX-2) expression and experimental radiation-induced mucositis. Oral Oncol 40 (2004) 170
14. Rose P.G., Halter S.A., and Su C.M. The effect of indomethacin on acute radiation induced gastrointestinal injury. A morphologic study. J Surg Oncol 49 (1992) 231
15. Berthrong M. Pathological changes secondary to radiation. World J Surg 10 (1986) 155
16. Bradley P.P., Priebat D.A., Christensen R.D., and Rothstein G. Measurement of cutaneous inflammation estimation of neutrophil content with an enzme marker. J Invest Dermatol 78 (1982) 206
17. Buege J.A., and Aust S.D. Microsomal lipid peroxidation. Methods Enzymol 52 (1978) 302
18. Mann W.J. Surgical management of radiation enteropathy. Surg Clin North Am 71 (1991) 977
19. Nguyen N.P., Antonie J.E., Dutta S., Karlsson U., and Sallah S. Current concepts in radiation enteritis and implications for future clinical trials. Cancer 95 (2002) 1151
20. Linard C., Ropenga A., Vozenin-Brotons M.C., Chapel A., and Mathe D. Abdominal irradiation increases inflammatory cytokine expression and activates NF-{kappa}B in rat ileal muscularis layer. Am J Physiol Gastrointest Liver Physiol 285 (2003) 556
21. Sime P.J., and O'Reilly K.M. Fibrosis of the lung and other tissues. New concepts in pathogenesis and treatment. Clin Immunol 99 (2001) 308
22. Lee T.Y., Chin G.S., Kim W.J., Chau D., Gittes G.K., and Longaker M.T. Expression of transforming growth factor beta 1, 2, 3 proteins in keloids. Ann Plast Surg 43 (1999) 179
23. Vozenin-Brotons M.C., Milliat F., Sabourin J.C., de Gouville A.C., Francois A., and Lasser P. Fibrogenic signals in patients with radiation enteritis are associated with increased connective tissue growth factor expression. Int J Radiat Oncol Biol Phys 56 (2003) 561
24. Langberg C.W., Hauer-Jensen M., Sung C.C., and Kane C.J. Expression of fibrogenic cytokines in rat small intestines after fractionated irradiation. Radiother Oncol 32 (1994) 36
25. Richter K.K., Langberg C.W., Sung C.C., and Hauer-Jensen M. Increased transforming growth factor beta immunoreactivity is independently associated with chronic injury in both consequential and primary radiation enteropathy. Int J Radiat Oncol Biol Phys 39 (1997) 187
26. Richter K.K., Fink L.M., Hughes B.M., Sung C.C., and Hauer-Jensen M. Is the loss of endothelial thrombomodulin involved in the mechanism of chronicity in late radiation enteropathy?. Radiother Oncol 44 (1997) 65
27. Fong C.Y., Pang L., Holland E., and Knox A.J. TGF-beta 1 stimulates IL-8 release, COX-2 expression, and PGE(2) release in human airway smooth muscle cells. Am J Physiol Lung 279 (2000) 201
28. Panes J., and Granger D.N. Neutrophils generate oxygen free radicals in rat mesenteric microcirculation. Gastroenterology 111 (1996) 981
29. Erbil Y., Oztezcan S., Giris M., et al. The effect of glutamine on radiation-induced organ damage. Life Sci 78 (2005) 376
30. Yeoh A.S.J., Bowen J.M., Gibson R.J., and Keefe D.M.K. Nuclear factor κB (NFκB) and cyclooxygenase-2 (Cox-2) expression in the irradiated colorectum is associated with subsequent histopathological changes. Int J Radiat Oncol Biol Phys 63 (2005) 1295
31. Lahey K.M., Koki A.T., and Masferrer J.L. Role of cyclooxygenases in angiogenesis. Curr Med Chem 7 (2000) 1163
32. Goddard D.H., Grossman S.L., Williams W.V., et al. Regulation of synovial cell growth. Coexpression of transforming growth factor beta and basic fibroblast growth factor by cultured synovial cells. Arthritis Rheumatol 35 (1992) 1296
33. Ben-Av P., Crofford L.J., Wilder R.L., and Hla T. Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin-1. A potential mechanism for inflammatory angiogenesis. FEBS Lett 372 (1995) 83
34. Lee Y.J., Galoforo S.S., Berns C.M., et al. Effect of ionizing radiation on AP-1 binding activity and basic fibroblast growth factor gene expression in drug-sensitive human breast carcinoma MCF-7 and multidrug-resistant MCF-7/ADR cells. J Biol Chem 270 (1995) 28790
35. Hurst P.A., and Edwards J.M. Chylous ascites and obstructive lymphoedema of the small bowel following abdominal radiotherapy. Br J Surg 66 (1979) 780
36. Rao S.S., Dundas S., and Holdsworth C.D. Intestinal lymphangiectasia secondary to radiotherapy and chemotherapy. Dig Dis Sci 32 (1987) 939
37. Hendel J., and Nielson O.H. Expression of cyclooxygenase mRNA in active inflammatory bowel disease. Am J Gastroenterol 92 (1997) 1170
38. Singer I.I., Kawka D.W., Schloemann S., Tessner T., Riehl T., and Stenson W.F. Cyclooxygenase-2 is induced in colonic epithelial cells in inflammatory bowel disease. Gastroenterology 115 (1998) 297
39. Tabernero A., Reimund J.M., Chasserot S., Muller C.D., and Andriantsitohaina R. Cyclooxygenase-2 expression and role of vasoconstrictor prostanoids in small mesenteric arteries from patients with Crohn's disease. Circulation 107 (2003) 1407
40. El Miedany Y., Youssef S., Ahmed I., and El Gaafary M. The gastrointestinal safety and effect on disease activity of etoricoxib, a selective cox-2 inhibitor in inflammatory bowel diseases. Am J Gastroenterol 101 (2006) 311
41. Matuk R., Crawford J., Abreu M.T., Targan S.R., Vasiliauskas E.A., and Papadakis K.A. The spectrum of gastrointestinal toxicity and effect on disease activity of selective cyclooxygenase-2 inhibitors in patients with inflammatory bowel disease. Inflamm Bowel Dis 10 (2004) 352
42. Aldemir M., Ozturk H., Erten C., and Buyukbayram H. The preventive effect of Rofecoxib in post operative intraperitoneal adhesions. Acta Chir Belg 104 (2004) 97
43. Greene A.K., Alwayn I.J.P., Nose V., et al. Prevention of intra-abdominal adhesions using the antiangiogenic COX-2 inhibitor celecoxib. Ann Surg 242 (2005) 140